Back to Authors

Rose, David

https://orcid.org/0000-0001-7616-6283

Mayo Clinic

University of Cincinnati

Citations 3

Management of Liver Cirrhosis in Percutaneous and Surgical Cardiac Interventions
Spadaccio, C., Mehta, Krishna, Pisani, Angelo , Osho, Asishana, Juarez‐Casso, Fernando, Alvaro, Domenico, Arif, Imran, Panza, Antonio, Vester, Russell S., Louis, Louis B., Sundt, Thoralf M., Crestanello, Juan, Alvaro, Domenico , Osho, Asishana A. , Spadaccio, Cristiano , Pisani, Angelo , Osho, Asishana , Juarez-Casso, Fernando, Alvaro, Domenico , Panza, Antonio , Louis, Louis B , Sundt, Thoralf , Crestanello, Juan A , Rose, David , Spadaccio, Cristiano , Nenna, Antonio , Juarez-Casso, Fernando M. , Arif, Imran, Vester, Russell Samuel , Sundt, Thoralf M. , Rose, David

Journal of the American Heart Association | February 24, 2026 | Volume: 15 | Issue: 5 | Pages: No page available

10.1161/jaha.125.045147 Get It

The systemic impairment that accompanies liver cirrhosis is known to carry a significant burden on death and postoperative complications in cardiovascular interventions. This review analyzes the impact of liver cirrhosis on short‐ and long‐term outcomes after cardiac surgery and percutaneous procedures, providing an evidence‐based guidance in the decision‐making process and perioperative management of these patients. Several parameters should be considered by the heart teams when assessing eligibility, indications for intervention, and perioperative management of these patients. Life expectancy, long‐term procedural outcomes, Child–Pugh or the Model for End‐Stage Liver Disease score, presence of gastroesophageal varices and hepatic venous pressure gradient were extrapolated as the main determinants in decision making in patients with cirrhosis. Assessment and treatment of gastroesophageal varices is mandatory. Hepatic venous pressure gradient values >20 mm Hg preclude patients from a surgical approach. Considering the poor prognosis of advanced liver cirrhosis, futile treatments should be avoided. A multidimensional heart team approach involving surgical, cardiologic, anesthesiologic, hepatological, and medical considerations is recommended.
Enhanced recovery protocols after surgery: A systematic review and meta‐analysis of randomized trials in cardiac surgery
Spadaccio, Cristiano , Salsano, Antonio , Pisani, Angelo , Nappi, Francesco , D’Alessandro, David A. , Sundt, Thoralf M. , Nappi, Francesco , Nenna, Antonio , Osho, Asishana A. , Crestanello, Juan A. , Engelman, Daniel T. , Rose, David

World Journal of Surgery | February 29, 2024 | Volume: 48 | Issue: 4 | Pages: 779-790

10.1002/wjs.12122 Get It

Abstract Background Previous meta‐analyses combining randomized and observational evidence in cardiac surgery have shown positive impact of enhanced recovery protocols after surgery (ERAS) on postoperative outcomes. However, definitive data based on randomized studies are missing, and the entirety of the ERAS measures and pathway, as recently systematized in guidelines and consensus statements, have not been captured in the published studies. The available literature actually focuses on “ERAS‐like” protocols or only limited number of ERAS measures. This study aims at analyzing all randomized studies applying ERAS‐like protocols in cardiac surgery for perioperative outcomes. Methods A meta‐analysis of randomized controlled trials (RCTs) comparing ERAS‐like with standard protocols of perioperative care was performed (PROSPERO registration CRD42021283765). PRISMA guidelines were used for abstracting and assessing data. Results Thirteen single center RCTs ( N = 1704, 850 in ERAS‐like protocol and 854 in the standard care group) were selected. The most common procedures were surgical revascularization (66.3%) and valvular surgery (24.9%). No difference was found in the incidence of inhospital mortality between the ERAS and standard treatment group (risk ratio [RR] 0.61 [0.31; 1.20], p = 0.15). ERAS was associated with reduced intensive care unit (standardized mean difference [SMD] −0.57, p < 0.01) and hospital stay (SMD −0.23, p < 0.01) and reduced rates of overall complications when compared to the standard protocol (RR 0.60, p < 0.01) driven by the reduction in stroke (RR 0.29 [0.13; 0.62], p < 0.01). A significant heterogeneity in terms of the elements of the ERAS protocol included in the studies was observed. Conclusions ERAS‐like protocols have no impact on short‐term survival after cardiac surgery but allows for a faster hospital discharge while potentially reducing surgical complications. However, this study highlights a significant nonadherence and heterogeneity to the entirety of ERAS protocols warranting further RCTs in this field including a greater number of elements of the framework.
Ischemic Mitral Regurgitation: A Multifaceted Syndrome with Evolving Therapies
Vinciguerra, Mattia , Grigioni, Francesco , Romiti, Silvia , Benfari, Giovanni , Rose, David , Spadaccio, Cristiano , Bellis, Antonio De, Greco, Ernesto , Greco, Ernesto , Benfari, Giovanni , Rose, David , Cimino, Sara , Grigioni, Francesco

Biomedicines | April 21, 2021 | Volume: 9 | Issue: 5 | Pages: 447

10.3390/biomedicines9050447 Get It

Dysfunction of the left ventricle (LV) with impaired contractility following chronic ischemia or acute myocardial infarction (AMI) is the main cause of ischemic mitral regurgitation (IMR), leading to moderate and moderate-to-severe mitral regurgitation (MR). The site of AMI exerts a specific influence determining different patterns of adverse LV remodeling. In general, inferior-posterior AMI is more frequently associated with regional structural changes than the anterolateral one, which is associated with global adverse LV remodeling, ultimately leading to different phenotypes of IMR. In this narrative review, starting from the aforementioned categorization, we proceed to describe current knowledge regarding surgical approaches in the management of IMR.